REGENXBIO INC (RGNX)
US75901B1070 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to RGNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.63. This target is 143.29% above the current price.
RGNX was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RGNX.
In the previous month the buy percentage consensus was at a similar level.
RGNX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-12 | Stifel | Maintains | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-08 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-03-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-06 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Baird | Maintains | Outperform -> Outperform |
| 2024-02-28 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-02-21 | Raymond James | Reiterate | Outperform |
| 2024-02-12 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-11-01 | Stifel | Initiate | Buy |
| 2023-10-05 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-10-04 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-08-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-03 | Chardan Capital | Reiterate | Buy |
| 2023-07-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-06-20 | Baird | Initiate | Outperform |
| 2023-06-02 | Baird | Initiate | Outperform |
| 2023-05-09 | Morgan Stanley | Maintains | Overweight |
| 2023-05-05 | Chardan Capital | Maintains | Buy |
| 2023-05-04 | RBC Capital | Maintains | Sector Perform |
| 2023-03-06 | Morgan Stanley | Maintains | Overweight |
| 2023-03-02 | Chardan Capital | Reiterate | Buy |
| 2023-01-23 | SVB Leerink | Maintains | Market Perform |
| 2022-11-21 | Morgan Stanley | Maintains | Overweight |
| 2022-11-04 | Chardan Capital | Maintains | Buy |
| 2022-11-04 | SVB Leerink | Maintains | Market Perform |
| 2022-10-04 | RBC Capital | Maintains | Sector Perform |
| 2022-09-09 | Morgan Stanley | Maintains | Overweight |
| 2022-08-10 | Morgan Stanley | Maintains | Overweight |